private:xerispharmaceuticals
|
726917
|
Jun 4th, 2019 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
6.4K
|
115.00
|
Open
|
Pharmaceuticals
|
Jun 4th, 2019 03:04PM
|
Jun 4th, 2019 03:04PM
|
Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The company’s proprietary XeriSol™ and XeriJect™ formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using syringes, auto-injectors, multi-dose pens, and infusion pumps. Xeris’ platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol™ and XeriJect™ offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system
|
Open
|
|
Open
|
180 N. Lasalle
|
Chicago
|
IL
|
US
|
60601
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 17th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 16th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 15th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 14th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 13th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 12th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 11th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 10th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:xerispharmaceuticals
|
726917
|
Feb 9th, 2018 12:00AM
|
Xeris Pharmaceuticals, Inc.
|
701
|
40.00
|
Open
|
Pharmaceuticals
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Xeris is an emerging pharmaceutical company dedicated to the development of patient-friendly injectable drugs to address important unmet medical needs while improving patient compliance, lowering total costs of treatment, and having a positive impact on patient and caregiver quality of life. With this singular focus on patient quality of life, each member of the Xeris team is working to develop novel products that improve upon existing products or enable delivery of novel drug substances, allowing for treatments not previously possible.
|
|
|
|
|
|
|
|
|
|
Xeris Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|